Novo Nordisk signs Anthropic deal to speed drug discovery with AI
The Danish drugmaker will use Claude models to work through complex biological questions and drug mechanics. It already uses the technology to generate trial reports, cutting patient documentation timelines from months to minutes.
2 min read